Comirnaty NDC 0069-2631

Product information

Brand name (proprietary)

Comirnaty

Generic name (nonproprietary)

covid-19 vaccine, mrna

Active ingredients

Bnt-162b2 omicron (Xfg) mrna — .042 mg/.418mL

Dosage form

Injection, Suspension

Route

Intramuscular

Labeler

Pfizer Laboratories Div Pfizer Inc

Product type

Vaccine

Marketing category

BLA — Biologics License ApplicationApplication BLA 125742

Marketing start

Aug 27, 2026

Listing expires

Dec 31, 2027

Identifiers

Product ID 0069-2631_0248cf65-e619-47eb-b9e2-355f9e797563SPL ID 0248cf65-e619-47eb-b9e2-355f9e797563

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N400069263110 followed by a unit qualifier and the quantity Copy

Package 00069-2631-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 125742

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.